Silk Road Medical, Inc
SILK
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.60M | -14.14M | -13.01M | -12.79M | -13.48M |
| Total Depreciation and Amortization | 953.00K | 925.00K | 931.00K | 925.00K | 956.00K |
| Total Amortization of Deferred Charges | 58.00K | 59.00K | 59.00K | 59.00K | 57.00K |
| Total Other Non-Cash Items | 10.35M | 9.40M | 8.80M | 8.57M | 8.78M |
| Change in Net Operating Assets | 1.86M | -11.57M | -5.23M | -3.56M | -929.00K |
| Cash from Operations | -3.38M | -15.32M | -8.45M | -6.80M | -4.62M |
| Capital Expenditure | -954.00K | -388.00K | -453.00K | -333.00K | -434.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.72M | 18.13M | -1.13M | 7.79M | -18.72M |
| Cash from Investing | -9.67M | 17.74M | -1.58M | 7.46M | -19.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.07M | -- | 1.06M | 130.00K | 1.59M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.07M | -- | 1.06M | 130.00K | 1.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.00K | 2.42M | -8.98M | 788.00K | -22.18M |
